Replies to post #400474 on Innovation Pharmaceuticals Inc (IPIX)

[Snowy_Owl]

I hope you're right. I read it as Alfasigma walking away entirely.

Was this a typo? Did you mean orally?
"Alfasigma should have pursued both routes at the same time of signing the original cheaper licensing deal especially since they now know it can be given intravenously."

[zandant]

More than just an enema. "July 22, 2019 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has executed a license agreement with Alfasigma S.p.A (“Alfasigma”) to develop and commercialize locally-administered Brilacidin (e.g., foam, enema, gel), on a worldwide basis, for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS)."